Today the OHSU Knight Cancer Institute announced that internationally renowned bioengineering and technology expert Mike Heller, Ph.D., will join the institute’s Cancer Early Detection Advanced Research Center, or CEDAR, to lead its technology efforts.
May is Melanoma Awareness Month, and the OHSU Knight Cancer Institute will again hold the “War on Skin Cancer Event” Saturday, May 20, from 9 a.m. to 2 p.m., to educate the community about sun safety and skin cancer risk factors.
A free War on Skin Cancer Event at OHSU gives attendees the chance to talk with experts, participate in fundraising, evaluate potential risk for melanoma, and more.
An OHSU and Oregon State University study finds aspirin may slow the spread of some types of colon and pancreatic cancer cells, Their findings are published in the American Journal of Physiology—Cell Physiology.
Today OHSU announced Mark B. Williams has accepted the role of chief strategy officer for the OHSU Knight Cancer Institute. This is a new position focused on overseeing the budget and long-term financial sustainability of the Knight Cancer Institute.
Restoring tumor-specific immunity is a treatment strategy that works well in melanoma and lung cancer patients. Now a new study out of the OHSU Knight Cancer Institute is reviving hope that the approach also may help men with life-threatening prostate ...
Nearly one year after completing the $1 billion Knight Cancer Challenge, OHSU today broke ground on its new cancer research building. The $160 million facility, funded by an investment from the state of Oregon, will reside north of the Collaborative ...
Nearly one year after completing the $1 billion Knight Cancer Challenge, OHSU today broke ground on its new cancer research building. The $160 million facility, funded by an investment from the state of Oregon, will reside north of the Collaborative ...